Where was this study done?
Study sites were in six countries.
Number of patients from each country who were included
in the assessment of how well belimumab worked
Brazil 177
Columbia 41
France 4
South Africa 19
United Kingdom 11
United States 196
0 50 100 150 200 250
Number of patients
Which patients were included in this study?
Studies have a list of requirements for patients who can enrol (inclusion criteria) and
those who can’t (exclusion criteria). For this study, the main inclusion and exclusion
criteria are listed below.
Men and women who self-identify as black race were included in the study if
they:
• Were at least 18 years old.
• Had SLE with symptoms of at least moderate severity.
• Tested positive for the presence of autoantibodies at two different time
points before starting the study treatment.
• Were on stable SLE treatment for at least one month before starting the
study treatment.